Bicycle Therapeutics plc (BCYC) Tops Q2 EPS by 36c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q2 EPS of ($0.77), $0.36 better than the analyst estimate of ($1.13). Revenue for the quarter came in at $9.36 million versus the consensus estimate of $6.13 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c
• Accendra Health scraps equity program, expects CEO successor by mid-2026
• Paramount Global (PARA) Tops Q2 EPS by 175c